There is an anti-Covid vaccine, patent-free and safe, which, however, does not find a partner.
An authentic paradox the one told by the Italian researcher Maria Elena Bottazzi.
“We are experiencing a difficult time with the coronavirus pandemic, the world is suffering, not only for health but also for the economy, there is an urgent need to intervene and vaccinate the poorest countries. Multinationals are not asked to change their way of working, but to think about how to help the rest of the world, favoring decolonization for the development of products even in the poorest countries, leaving aside at this time the business: other pandemics will arrive, whether it is the coronavirus, another virus or another pathogen, we will have the same problem. It is a moment of great emergency and we must all help each other because we all live in the same world! “, There is all the philosophy and greatness of the scientist of Italian origin and a Honduran citizen. Maria Elena Bottazzi in the intense interview this morning, in the broadcast 37e2, his Popular Radio, conducted by Vittorio Agnoletto. doctor and coordinator of the European campaign Right2cure No Profit on Pandemic, which is fighting for the temporary suspension of vaccine patents, requested by India and South Africa since October 2020.
In fact Maria Elena Bottazzi, co-director of Texas Children’s Hospital and Baylor College of Medicine Vaccine Development Center, has blown everyone away with his vaccine Corbevax offered to the world without a patent: the news of its precious gift, which started quietly at the end of December, is making a tour of the planet, arousing debate and interest. A 360-degree opening that, however, is colliding with an unthinkable wall: Maria Elena Bottazzi and her Corbevax, made with a known and tested technology such as that of the vaccine for the‘hepatitis B, widely known and available, did not find partner, pleasant until today in USA and in EU, despite being effective against variants Alpha, Beta, and Delta and testing for Omicron scheduled for late January, early February. “It is a very serious fact – said Vittorio Agnoletto – we have a promising vaccine, with strong protection also for the transmission of the virus, with a very low production cost of just 1,5 euro per dose, but evidently here the market is contracted out to the multinationals of the drug, to which the choices of the EU are subservient and that nail us to pay abnormal costs: in Italy there is Rei Thera, biopharmaceutical company that deals with the development, production and clinical translation of genetic vaccines and biopharmaceutical products for advanced therapies, because it could not be a partner? Why the Italian government and European governments are silent?”
”Our institutions, private but absolutely non-profit – answered Maria Elena Bottazzi – are interested in bringing benefits to the health of the world population, our mission is to develop products, such as the vaccine and decolonize them, promoting knowledge, research and production in poor countries: anyone can come to us and learn, and if they can’t do it we help them ”. It is quite a new one paradigm proposed to the world, the total opening of research sources, the sharing of technologies, processes and results for a total coverage of world needs.